M R Nelson

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. pmc The mummy's curse: historical cohort study
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran 3181, Australia
    BMJ 325:1482-4. 2002
  2. ncbi request reprint A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs
    M Nelson
    Department of Epidemiology and Preventive Medicine, Monash Medical School, Alfred Hospital, Prahran, Australia
    Am J Hypertens 14:98-105. 2001
  3. ncbi request reprint Managing 'metabolic syndrome' and multiple risk factors
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Victoria
    Aust Fam Physician 33:201-5. 2004
  4. ncbi request reprint Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE)
    Mark Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahan, Victoria, Australia
    Drugs Aging 20:897-903. 2003
  5. ncbi request reprint Indigenous voices and community trials. Report on the 2004 General Practice and Primary Health Care Research Conference and Australian Association for Academic General Practice Research Forum, Brisbane, 2-5 June, 2004
    Mark Nelson
    Department of General Practice, Monash University, Victoria
    Aust Fam Physician 33:551. 2004
  6. ncbi request reprint Recruitment in primary care research. Primary Care Alliance for Clinical Trials (PACT)
    Mark Nelson
    Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne
    Aust Fam Physician 33:1039-40. 2004
  7. ncbi request reprint Factors influencing family physician adherence to hypertension treatment guideline recommendations on the initiation of pharmacotherapy: questionnaire survey
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran, Australia
    Am J Cardiovasc Drugs 3:437-41. 2003
  8. ncbi request reprint Short-term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in the second Australian National Blood Pressure Study (ANBP2)
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran, Australia
    Am J Hypertens 16:39-45. 2003
  9. pmc Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran 3181, Australia
    BMJ 325:815. 2002
  10. ncbi request reprint PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998
    M R Nelson
    Department of Epidemiology and Preventive Medicine, Monash Medical School, Alfred Hospital, Melbourne, Vic
    Med J Aust 174:565-8. 2001

Collaborators

Detail Information

Publications38

  1. pmc The mummy's curse: historical cohort study
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran 3181, Australia
    BMJ 325:1482-4. 2002
    ..To examine survival of individuals exposed to the "mummy's curse" reputedly associated with the opening of the tomb of Tutankhamen in Luxor, Egypt, between February 1923 and November 1926...
  2. ncbi request reprint A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs
    M Nelson
    Department of Epidemiology and Preventive Medicine, Monash Medical School, Alfred Hospital, Prahran, Australia
    Am J Hypertens 14:98-105. 2001
    ..Once therapy has been started, treating physicians have difficulty in selecting patients for withdrawal and have concerns regarding patient safety and their own legal liability...
  3. ncbi request reprint Managing 'metabolic syndrome' and multiple risk factors
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Victoria
    Aust Fam Physician 33:201-5. 2004
    ..This syndrome is associated with both insulin resistance and behaviourally modifiable risk factors such as smoking, physical activity and unhealthy diet...
  4. ncbi request reprint Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE)
    Mark Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahan, Victoria, Australia
    Drugs Aging 20:897-903. 2003
    ..This sample size has a power of 87% to detect a 15% reduction in primary events in the aspirin group, with an anticipated combined primary event rate of 20 per 1000 patient years...
  5. ncbi request reprint Indigenous voices and community trials. Report on the 2004 General Practice and Primary Health Care Research Conference and Australian Association for Academic General Practice Research Forum, Brisbane, 2-5 June, 2004
    Mark Nelson
    Department of General Practice, Monash University, Victoria
    Aust Fam Physician 33:551. 2004
  6. ncbi request reprint Recruitment in primary care research. Primary Care Alliance for Clinical Trials (PACT)
    Mark Nelson
    Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne
    Aust Fam Physician 33:1039-40. 2004
  7. ncbi request reprint Factors influencing family physician adherence to hypertension treatment guideline recommendations on the initiation of pharmacotherapy: questionnaire survey
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran, Australia
    Am J Cardiovasc Drugs 3:437-41. 2003
    ....
  8. ncbi request reprint Short-term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in the second Australian National Blood Pressure Study (ANBP2)
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran, Australia
    Am J Hypertens 16:39-45. 2003
    ..The identification of simple predictors would assist the family physician to select who may or may not have their medication ceased...
  9. pmc Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran 3181, Australia
    BMJ 325:815. 2002
    ..To identify simple long term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in elderly patients in general practice...
  10. ncbi request reprint PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998
    M R Nelson
    Department of Epidemiology and Preventive Medicine, Monash Medical School, Alfred Hospital, Melbourne, Vic
    Med J Aust 174:565-8. 2001
    ....
  11. ncbi request reprint Australians at risk: management of cardiovascular risk factors in the REACH Registry
    Christopher Reid
    NHMRC Centre for Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Australia
    Heart Lung Circ 17:114-8. 2008
    ..However little is known of the translation of evidence into clinical practice in terms of current management practice and risk factor control in high-risk patients in Australia...
  12. ncbi request reprint Gastro-oesophageal reflux disease--impact of guidelines on GP management
    Catherine N Kirby
    Department of General Practice, Monash University, East Bentleigh, Victoria
    Aust Fam Physician 37:73-7. 2008
    ..This program examined the impact of clinical guidelines and a 3 year self audit process on general practitioners' diagnosis and management of gastro-oesophageal reflux disease...
  13. pmc Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals
    E K Chowdhury
    Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    J Hum Hypertens 27:545-51. 2013
    ..These findings identify clinical markers that can be targeted for intervention, but also demographic factors related to service delivery, which may provide further opportunity for achieving better BP control in hypertensive elderly. ..
  14. pmc Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study
    Geoffrey A Head
    Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 8008, Australia
    BMJ 340:c1104. 2010
    ..We aimed to derive age and sex related ambulatory blood pressure equivalents to clinic blood pressure thresholds for diagnosis and treatment of hypertension...
  15. ncbi request reprint Identifying the health and mental health information needs of people with coronary heart disease, with and without depression
    Ciaran Pier
    School of Psychology, Deakin University, Melbourne, Vic, Australia
    Med J Aust 188:S142-4. 2008
    ..To identify the health and mental health information needs of people with coronary heart disease (CHD), with and without comorbid depression...
  16. ncbi request reprint Is egg hypersensitivity a contraindication to influenza vaccine?
    Mark R Nelson
    Department of Epidemiology and Preventive Medicine, Alfred Hospital, Department of General Practice, Monash University, Victoria
    Aust Fam Physician 32:932. 2003
  17. ncbi request reprint Implementing a research governance framework for clinical and public health research
    Stephanie J Poustie
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic, Australia stephanie poustieATbigpond com
    Med J Aust 185:623-6. 2006
    ..The need for participant confidentiality, privacy and data security was found to be understood, and adhered to widely by all researchers. An evaluation of the effect of audit on researchers found that the process was well accepted...
  18. ncbi request reprint Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2)
    Mark R Nelson
    Discipline of General Practice, University of Tasmania, Hobart, TAS, Australia
    Med J Aust 185:487-9. 2006
    ..To investigate whether responses to a previously validated four-item medication adherence questionnaire were associated with adverse cardiovascular events...
  19. ncbi request reprint Secondary prevention of CHD
    Mark R Nelson
    School of Medicine, University of Tasmania
    Aust Fam Physician 34:433-40. 2005
    ..It is considered essentially preventable. Risk of future events is highest in those who already have manifest disease (secondary prevention) and hence are likely to benefit from aggressive therapy...
  20. ncbi request reprint Cardiovascular risk factor control in Australia: current status and implications for the future
    Christopher M Reid
    Aust Fam Physician 34:405-6. 2005
  21. ncbi request reprint Predictors of failure to initiate randomized treatment in a large trial of antihypertensive drug therapy in the aged
    Mark R Nelson
    Discipline of General Practice, University of Tasmania, Hobart, Australia
    Am J Hypertens 18:885-8. 2005
    ....
  22. ncbi request reprint Research in the aged
    Mark R Nelson
    Aust Fam Physician 33:773. 2004
  23. ncbi request reprint Coronary heart disease risk prediction by general practitioners in Victoria
    Anna Peeters
    Med J Aust 180:252. 2004
  24. ncbi request reprint What's new in research that should change the way we detect and treat hypertension?
    Mark R Nelson
    Aust Fam Physician 33:949, 954. 2004
  25. ncbi request reprint Is primary care research a lost cause?
    Mark R Nelson
    Aust Fam Physician 32:488. 2003
  26. ncbi request reprint Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study
    Mark R Nelson
    Menzies Research Institute, University of Tasmania, Hobart, TAS, Australia
    Med J Aust 189:105-9. 2008
    ..To determine the feasibility of performing a large clinical trial of the use of aspirin for the primary prevention of cardiovascular disease in older participants--the ASPirin in Reducing Events in the Elderly (ASPREE) trial...
  27. pmc Maraviroc for previously treated patients with R5 HIV-1 infection
    Roy M Gulick
    Weill Cornell Medical College, New York, NY 10065, USA
    N Engl J Med 359:1429-41. 2008
    ..CC chemokine receptor 5 antagonists are a new class of antiretroviral agents...
  28. ncbi request reprint Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection
    John F Morlese
    AIDS 17:1411-3. 2003
  29. doi request reprint Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
    Gerd Fatkenheuer
    Universitätsklinik Köln, Cologne, Germany
    N Engl J Med 359:1442-55. 2008
    ....
  30. ncbi request reprint Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners
    Mark R Nelson
    Med J Aust 180:140. 2004
  31. ncbi request reprint Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study
    Gail V Matthews
    Department of HIV Medicine, Chelsea Hospital, London, UK
    AIDS 16:53-61. 2002
    ....
  32. ncbi request reprint The verdict from ALLHAT
    Mark R Nelson
    Med J Aust 178:304. 2003
  33. ncbi request reprint Public funding of large-scale clinical trials in Australia
    John J McNeil
    Med J Aust 179:519-20. 2003
  34. ncbi request reprint The JNC 7 hypertension guidelines
    Mark R Nelson
    JAMA 290:1312; author reply 1314-5. 2003
  35. pmc Interpretation of screening test results: best performers have the most to learn
    Mark R Nelson
    BMJ 333:397. 2006
  36. pmc Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70
    Mark R Nelson
    Discipline of General Practice, School of Medicine, University of Tasmania, Hobart, TAS 7001, Australia
    BMJ 330:1306. 2005
    ..To investigate the routine use of low dose aspirin in people aged > or = 70 without overt cardiovascular disease...
  37. ncbi request reprint COX-2 inhibitors: exemplars of the drug-safety conundrum
    Mark R Nelson
    Med J Aust 182:262-3. 2005
    ..Using clinical trials to assess long-term drug safety is problematic; in Australia, simple data linkage based on Medicare numbers may provide useful monitoring information...
  38. ncbi request reprint Self-rated health in a population of expatriate workers and partners in Riyadh, Saudi Arabia
    Christopher M T Matthews
    King Abdulaziz Medical City, Saudi Arabian National Guard Health Affairs, MC 4040, PO Box 22490, Riyadh 11426, Kingdom of Saudi Arabia
    Occup Med (Lond) 54:585-6. 2004
    ..The psychological and physiological effects of this adaptation process may be reflected in changes in self-rated general health...